09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3539<br />
Ka<strong>za</strong>lo podnositelja <strong>za</strong>htjeva <strong>za</strong><br />
proširenje europskih prijava patenata<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
77 Elektronika Müszeripari Kft., HU B01L 3/00 (2006.01)<br />
EP 2086679 * CONTAINER FOR ANALYZING LIQUID<br />
G01N 21/11 (2006.01)<br />
G01N 33/493 (2006.01)<br />
A. N. Nesmeyanov Institute of<br />
Organoelement Compounds, The<br />
EP 2086924 *<br />
Russian Academy of Science (INEOS<br />
RAS), RU<br />
C07C 229/24 (2006.01)<br />
C07B 59/00 (2006.01)<br />
C07C 251/24 (2006.01)<br />
C07C 3<strong>09</strong>/73 (2006.01)<br />
C07C 271/22 (2006.01)<br />
C07D 207/16 (2006.01)<br />
A61K 51/04 (2006.01)<br />
A61K 31/195 (2006.01)<br />
Abbott Biotechnology Ltd., BM C07K 16/00 (2006.01)<br />
G01N 31/00 (2006.01)<br />
C07K 1/00 (2006.01)<br />
Abbott Cardiovascular Systems Inc., US A61L 27/38 (2006.01)<br />
A61L 27/48 (2006.01)<br />
A61L 27/52 (2006.01)<br />
Abbott GmbH & Co. KG, DE A61K 39/395 (2006.01)<br />
A61K 31/711 (2006.01)<br />
C12N 15/<strong>09</strong> (2006.01)<br />
Abbott GmbH & Co. KG, DE A61K 8/18 (2006.01)<br />
A61Q 13/00 (2006.01)<br />
C12P 21/06 (2006.01)<br />
Abbott Laboratories, US A61K 39/395 (2006.01)<br />
Abbott Laboratories, US A61K 31/675 (2006.01)<br />
Abbott Laboratories, US G01N 15/14 (2006.01)<br />
G01N 33/50 (2006.01)<br />
ABBOTT LABORATORIES, US A61K 39/395 (2006.01)<br />
A61K 31/711 (2006.01)<br />
C12N 15/<strong>09</strong> (2006.01)<br />
Abbott Laboratories, US B65D 41/34 (2006.01)<br />
B65D 41/04 (2006.01)<br />
Abbott Laboratories, US G01N 15/02 (2006.01)<br />
G01N 15/14 (2006.01)<br />
G01N 21/17 (2006.01)<br />
G01N 29/24 (2006.01)<br />
G01N 33/48 (2006.01)<br />
Abbott Laboratories, US G01N 33/53 (2006.01)<br />
Abbott Laboratories, US G01N 33/53 (2006.01)<br />
G01N 33/543 (2006.01)<br />
Abbott Laboratories, US A61K 31/445 (2006.01)<br />
C07D 211/00 (2006.01)<br />
Abbott Laboratories, US C07D 451/14 (2006.01)<br />
A61K 31/395 (2006.01)<br />
Abbott Laboratories, US C07K 16/08 (2006.01)<br />
C12P 21/08 (2006.01)<br />
C07H 21/00 (2006.01)<br />
C12Q 1/00 (2006.01)<br />
C12Q 1/70 (2006.01)<br />
G01N 33/53 (2006.01)<br />
G01N 33/576 (2006.01)<br />
Abbott Laboratories, US G01N 35/00 (2006.01)<br />
B01L 11/00 (2006.01)<br />
Abraxis BioScience, Inc., US C07D 225/06 (2006.01)<br />
C07D 401/12 (2006.01)<br />
C07D 407/12 (2006.01)<br />
A61K 31/395 (2006.01)<br />
A61P 35/00 (2006.01)<br />
ACRO - KHLimburg, BE A01D 46/30 (2006.01)<br />
EP 2089428 *<br />
EP 2<strong>09</strong>95<strong>09</strong> *<br />
EP 2<strong>09</strong>7104 *<br />
EP 2<strong>09</strong>9414 *<br />
EP 2<strong>09</strong>1563 *<br />
EP 2<strong>09</strong>4276 *<br />
EP 2<strong>09</strong>5<strong>09</strong>3 *<br />
EP 2<strong>09</strong>7104 *<br />
EP 2<strong>09</strong>7332 *<br />
EP 2<strong>09</strong>7732 *<br />
EP 2<strong>09</strong>7749 *<br />
EP 2<strong>09</strong>7750 *<br />
EP 2<strong>09</strong>9454 *<br />
EP 2<strong>09</strong>9795 *<br />
EP 2<strong>09</strong>9825 *<br />
EP 2100149 *<br />
EP 2<strong>09</strong>1919 *<br />
EP 2086308 *<br />
[F-18]-LABELED L-GLUTAMIC ACID, [F-18]-LABELED<br />
L-GLUTAMINE, DERIVATIVES THEREOF AND USE<br />
THEREOF AND PROCESSES FOR THEIR<br />
PREPARATION<br />
CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES<br />
METHODS&COMPOSITIONS FOR TREATING TISSUE<br />
USING SILK PROTEINS<br />
NEW A-BETA CONFORMER SELECTIVE ANTI-A-<br />
BETA GLOBULOMER MONOCLONAL ANTIBODIES<br />
HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND<br />
METHODS FOR PRODUCING<br />
NEUTRALIZING MONOCLONAL ANTIBODIES<br />
AGAINST THE NOGO-66 RECEPTOR (NGR) AND<br />
USES THEREOF<br />
ANTI-VIRAL COMPOUNDS<br />
METHOD FOR DETERMINATION OF NUCLEATED<br />
RED BLOOD CELLS AND LEUKOCYTES IN A WHOLE<br />
BLOOD SAMPLE IN AN AUTOMATED HEMATOLOGY<br />
ANALYZER<br />
NEW A-BETA CONFORMER SELECTIVE ANTI-A-<br />
BETA GLOBULOMER MONOCLONAL ANTIBODIES<br />
CONTAINER CLOSURE ASSEMBLY<br />
METHOD AND APPARATUS FOR RAPIDLY<br />
COUNTING AND IDENTIFYING PARTICLES IN<br />
SUSPENSION BY SCANNING<br />
ASSAY FOR CARDIAC TROPONIN<br />
AUTOANTIBODIES<br />
IMMUNOASSAY OF ANALYTES IN SAMPLES<br />
CONTAINING ENDOGENOUS ANTI-ANALYTE<br />
ANTIBODIES<br />
AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR<br />
ANTAGONISTS<br />
AZAADAMANTANE DERIVATIVES AND THEIR USES<br />
AS NICOTINIC ACETYLCHOLINE RECEPTORS<br />
LIGANDS<br />
RECOMBINANT ANTIBODIES AGAINST HEPATITIS C<br />
VIRUS AND METHODS OF OBTAINING AND USING<br />
SAME<br />
LIQUID WASTE MANAGEMENT SYSTEM<br />
DERIVATIVES OF 18-AMINO SUBSTITUTED<br />
ANALOGS OF THE GELDAMYCIN HYDROQUINON<br />
WITH CYTOTOXIC ACTIVITY FOR THE TREATMENT<br />
OF CANCER<br />
AUTONOMOUS FRUIT PICKING MACHINE<br />
ISSN 1331-2030